Piscataqua Savings Bank’s Biogen BIIB Stock Holding History

Piscataqua Savings Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3	Closed	-$646	–	350
2024 Q1	$646	Buy	+3	New	+$703	﹤0.01%	386
2021 Q2	–	Sell	-165	Closed	-$46K	–	327
2021 Q1	$46K	Buy	+165	New	+$44.5K	0.04%	156

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Piscataqua Savings Bank's BIIB Position: Q2 2024 in Review

Piscataqua Savings Bank sold out of Biogen (BIIB) in Q2 2024, closing a stake of 3 shares — an estimated $646 sold.

Piscataqua Savings Bank first reported a position in BIIB in Q1 2021 and held it in 2 quarters. The position peaked at $46K in Q1 2021. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

Piscataqua Savings Bank reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
Piscataqua Savings Bank sold 3 Biogen shares in Q2 2024, an estimated $646.
Piscataqua Savings Bank first reported a position in Biogen in Q1 2021 and held it in 2 quarters.
Piscataqua Savings Bank's Biogen position peaked at $46K in Q1 2021.
943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Piscataqua Savings Bank's 13F filing for Q2 2024, filed 12 Jul 2024.